Salicor Patch
Product Images NDC 83881-501

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Salicor (NDC 83881-501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinic Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosing (Picture1)

Illustration showing three steps for using a transdermal patch: 1) cutting open the patch packaging with scissors, 2) peeling away the backing from the patch, and 3) applying the patch to the skin, specifically the upper arm.*

FDA Label Image

Carton Back (Salicor Carton Back 092525)

Drug Facts panel for Salicor patch with active ingredient triethanolamine salicylate 10% as an NSAID. The panel includes warnings, directions for adult use, other information on storage and pain relief onset, and inactive ingredients. It advises external use only, cautions for certain medical conditions, pregnancy, and disposal instructions. Contact information for questions is provided.*

FDA Label Image

Carton Front (Salicor Carton Front 092525)

Packaging label for Salicor transdermal system patch containing triethanolamine salicylate 10%. The label indicates a package of 15 systems measuring 6 cm by 9.5 cm (2.4 in x 3.75 in), with features highlighting design for active wear, fast-acting, all-night hold, and water-resistant properties. Labeled as prescription only and distributed by Clinic Pharma.*

FDA Label Image

Ppi Back (Salicor Package Insert Back 092525)

Prescribing information text for Salicor (triethanolamine salicylate) transdermal patch includes local anesthetic warnings, overdose symptoms, pregnancy category, pharmacodynamics, pharmacokinetics, metabolism, excretion, nonclinical toxicology, storage, and handling instructions. It details potential drug interactions, pediatric use, and safety measures. Manufactured by Clinic Pharma, this information focuses on clinical pharmacology and safe usage guidelines.*

FDA Label Image

Ppi Front (Salicor Package Insert Front 092525)

Drug facts and prescribing information for Salicor (triethanolamine salicylate 10%) transdermal system. The text covers indications, dosage and administration instructions, contraindications, warnings and precautions, adverse reactions, fetal toxicity warnings, and drug interactions. It is detailed, including usage instructions, potential allergic reactions, and serious adverse event warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.